Global Neurorehabilitation Devices Market Research Report?Forecast till 2025


Market Overview

Global Neurorehabilitation Devices Market is anticipated to reach a CAGR of 16.4% during the forecast period. The common neurological diseases are stroke, Parkinson’s disease, spinal cord injury, severe brain injury, spasticity, and cognitive disorders; the devices used in its treatment are Neurorehabilitation Devices. These devices are intended to facilitate learning or relearning of motor skills. The technologies are advanced to provide the effectiveness of rehabilitation strategies to the patients and it is proven that the adoption of these devices improved the intensity and quality of neurorehabilitation and ensures optimal rehabilitation of patients with neurological diseases.
The global Neurorehabilitation Devices Market is forecasted to witness significant growth during the review period because of safe and feasible treatment and effective results and it provides the possibility of home rehabilitation and remote monitoring systems. The neurorehabilitation devices demand is rising because of the increasing count of neurological diseases, the emergence of robotic rehabilitation, a surge in the old age population, and the influence of the gaming systems in neurorehabilitation. Additionally, the strict government regulatory policies and rising requirements of skilled professionals are estimated to hinder the market growth during the forecast period.

Market Segmentation

The Global Neurorehabilitation Devices Market has been segmented by type, application, and end-user. Based on the type segment, the market is divided into neuro-robotic devices, wearable devices, non-invasive stimulators, and brain-computer interfaces.
By application category, the global neurorehabilitation devices market is classified as brain stroke, Parkinson’s disease, multiple sclerosis, spinal cord injury, cerebral palsy, schizophrenia, and others. Base on the end-user segment, the market is sub-divided into rehabilitation centers, hospitals & clinics, and home care.

Regional Analysis

The region-specific analysis of the global neurorehabilitation devices market has been segmented into the Americas, Europe, Asia-Pacific, and Rest of the World.
The Americas are leading the global neurorehabilitation devices market during the forecast period owing to well-established market payers, an increasing number of neurological disease cases, and an increasing number of product launches, increasing geriatric population, and increased investment in the investigation for the development of neurorehabilitation devices.
Europe is anticipated as the second-largest market contributor to the global neurorehabilitation devices market. The key factors for regional growth are the increasing prevalence of neurological diseases, product approvals, and the existing well-established economies.
Asia-Pacific is evaluated the rapid expansion in the global market during the forecast period owing to rising old aged population and an increased number of neurological diseases in this region. The developing healthcare sector and rising neurological diseases cause steady growth for the rest of the world in the global market.

Major Players
The key market players in the Global Neurorehabilitation Devices Market are Hocoma AG (Switzerland) Ekso Bionics Holdings, Neuro Rehab VR (US), Neofect (US), Bioness Inc. (US), Bionik Laboratories Corp. (Canada), Inc. (the US), ReWalk Robotics Ltd (Israel), Eodyne (Spain), Reha Technology AG (Switzerland), Rex Bionics Ltd (New Zealand).

We are continuously tracking the impact of COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations and many other useful insights.